RNV ReNerve Limited

ASX · AU · Healthcare · Medical Devices & Supplies · renerve.com.au

—Mkt Cap: —P/E: —1d ago

ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops N…

Industry Peers

Medical Devices & Supplies

Screen all

Shoulder Innovations, Inc.

$382.44MUSDP/E 23.0

TEVO

Tevano Systems Holdings Inc.

$422.8KUSD

MMEDV

MiniMed Group, Inc. Common Stock When Issued

—

Key Statistics

Company

Market Cap—

Enterprise Value8.28M USD

Revenue (TTM)352.70K USD

Gross Profit187.51K USD

Net Income (TTM)-3.85M USD

Revenue/Share0.0030 AUD

Last Price—

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees—

CountryAU

SectorHealthcare

IndustryMedical Devices & Supplies

ISINAU0000358616

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-1.85

EV/Revenue23.47

P/S26.18

P/B4.28

EPS (TTM)-0.03

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin53.16%

Oper. Margin-1007.00%

EBITDA Margin0.00%

Profit Margin-1091.87%

ROE-175.44%

ROA-122.90%

Growth

Revenue Growth104.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.01M USD

CapEx (TTM)101.85K USD

FCF Margin-913.38%

FCF Yield—

Net Debt-889.08K USD

Net Debt/EBITDA0.20

Balance Sheet

Debt/Equity0.06

Current Ratio3.13

Quick Ratio2.35

Book Value/Sh0.02 AUD

Cash/Share0.0090 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 AUD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.173.50M

Float92.79M

Insiders58.08%

Institutions1.29%

Technical

SMA 500.0768 AUD

SMA 2000.0901 AUD

Beta—

S&P 52W Chg16.44%

Avg Vol (30d)—

Avg Vol (10d)72.04K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—